São Paulo School of Advanced Science on Medicines: from Target to Market |
A décima edição da Summer School on Medicines (SSM10) - Medicines: from Target to Market será realizada de 16 a 23 de março de 2018, em Ribeirão Preto (SP), pela primeira vez no Brasil.
O objetivo da SSM10 é promover intensa interação entre pesquisadores acadêmicos e da indústria que atuem em diferentes etapas da descoberta de fármacos, com estudantes e jovens profissionais.
Os assuntos a serem abordados incluem desde a identificação de moléculas e alvos até o lançamento do medicamento no mercado, passando por temas como ensaios pré-clínicos e clínicos, regulamentação, proteção intelectual, criação de startups, comercialização, entre outros. Também incluem discussão de casos e apresentações orais e de pôster.
As sessões da SSM10 ocorrerão na FMRP/USP e no Parque Tecnológico Supera, onde também serão realizadas visitas a laboratórios de pesquisa e startups.
O SSM10 será inteiramente realizado em inglês, tendo ocorrido anteriormente em Montreal (Canadá), Toulouse (França) e Barcelona (Espanha).
Para os candidatos selecionados, a FAPESP oferecerá auxílios integrais e parciais a estudantes de pós-graduação e jovens pesquisadores atuantes no tema da SSM10, de qualquer parte do mundo, exceto aqueles da cidade onde será realizado o evento.
-
Instituição
Faculdade de Medicina de Ribeirão Preto - FMRP/USP
-
Área de conhecimento
Medicina
-
Pesquisador Responsável
Claudio Miguel da Costa Neto
-
Nº do Processo FAPESP
2017/17382-4
-
Período
16/03/2018 a 23/03/2018
-
Inscrições
Encerradas
-
Site
-
Cidade
Ribeirão Preto
-
Palavras-chave
-
Programa
Ocultar
PRELIMINARY PROGRAM:
FRIDAY, March 16th – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
REGISTRATION, KEYNOTE LECTURES, AND POSTER PRESENTATION
14:00 – 16:00 Registration & Poster placing
16:00 – 16:15 OFFICIAL OPENING
Chair: The Organizing Committee
16:15 – 17:15 Keynote Opening Lecture 1 (KNL1)
*T.B.A.17:15 – 18:00 Keynote Opening Lecture 2 (KNL2)
Carlos Henrique de Brito Cruz, Scientific Director of FAPESP, Sao Paulo, Brazil.18:00 – 20:00 Welcome Reception with Poster presentations from students
SATURDAY, March 17th – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION I: DRUG R&D, AN OVERVIEW FROM IDEA TO MARKET
Chairperson: Jordi Quintana & Claudio Costa-Neto
09:00 – 09:45 (L1) Drug Discovery overview: from idea to drug candidate
Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada.
09:45 – 10:30 (L2) Overview on Clinical trials
Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada.
10:30 – 11:00 Coffee Break
11:00 – 12:00 (L3) Overview on Business Development
Steven Xanthoudakis, Merck Frosst Centre for Therapeutic Research in Montreal, Canada.
12:00 – 14:00 Lunch
SESSION II: TARGET-BASED DRUG DISCOVERY
Chairperson: Jordi Quintana & Claudio Costa-Neto
14:00 – 15:00 (L4) Chemical biology for Drug-Discovery
Jordi Quintana, Barcelona Scientific and Technological Park, Barcelona, Spain.
15:00 – 16:00 (L5) From basic to updated concepts in Drug-Discovery Pharmacology
André S. Pupo, State University of Sao Paulo, UNESP, Botucatu, SP, Brazil
16:00 – 16:30 Coffee Break
16:30 – 17:15 (L6) Drug Design based on target structure
Xavier Deupi, Paul Scherrer Institute, Switzerland
17:15 – 18:00 (L7) Hands on: structure analysis and drug/target modeling
Xavier Deupi, Paul Scherrer Institute, Switzerland
18:00 – 19:00 Poster Discussion
SUNDAY, March 18th – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION III: ORAL PRESENTATIONS FROM STUDENTS
09:00 – 10:30 Oral Presentations from Students
10:30 – 11:00 Coffee Break
SESSION IV: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART I)
Chairperson: Denis DeBlois, Pierre Cordelier
11:00 – 12:00 (L8) ADME (Pharmacokinetics / Pharmacodynamics)
*T.B.A.
12:00 – 14:00 Lunch
14:00 – 15:00 (L9) New classes of biological drugs: cell and gene therapy products
Pierre Cordelier, INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France.
15:00 – 16:00 (L10) Drug Discovery of dendrimers: from discovery to creation of a startup
Rémy Poupot, CHU Purpan, University Paul Sabatier, Toulouse, France
16:00 – 16:30 Coffee Break
16:30 – 17:15 (L11)
*T.B.A.
17:15 – 18:00 (L12) Discovery and development of new GPCR biased drugs
Claudio Costa-Neto, Ribeirao Preto Medical School, USP
18:00 – 19:00 Poster Discussion
MONDAY, March 19th – 2018
Venue: SUPERA Technological Park.
SESSION V: CASE STUDY IN DRUG DISCOVERY AND DEVELOPMENT
Chairperson: Denis DeBlois, Rémy Poupot, Pierre Cordelier
09:00 – 09:30 Case presentation and outline of challenges
09:30 – 10:30 Group session (students work in small teams)
10:30 – 11:00 Coffee Break
11:00 – 12:30 Each team reports / General discussion
12:30 – 14:00 Lunch
SESSION VI: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART II)
Chairperson: Roger Chammas (School of Medicine, University of Sao Paulo)
14:00 – 15:00 (L13) Toxicology / Preclinical Safety
Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada
15:00 – 16:00 (L14) Pre-Clinical Development
Pierre Cordelier , INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France
16:00 – 16:30 Coffee Break
16:00 – 18:00 Visit SUPERA Technological Park
TUESDAY, March 20th – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION VII: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART III)
09:00 – 09:45 (L15) Illustrative cases presented by an entrepreneur (I): From discovery to pharmaceutical development
Invited Speaker: Robson A. S. Santos, Professor at UFMG and founder of Labfar, Belo Horizone, MG, Brazil.
09:45 – 10:30 (L16) Learning and confirming trials
Mark Kester, University of Virginia, USA
10:30 – 11:00 Coffee Break
11:00 – 12:00 (L17) Illustrative cases presented by an entrepreneur (II): Medical Devices
Invited Speaker: Jarbas Caiado de Castro Neto, Professor at USP/São Carlos and founder of Opto
12:00 – 14:00 Lunch
14:00 – 15:00 (L18) Regulatory agencies
*T.B.A.
15:00 – 18:00 Visit Laboratories at University of Sao Paulo Campus
WEDNESDAY, March 21st – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION VIII: CLINICAL DEVELOPMENT & REGULATORY
Chairperson: Denis DeBlois
09.00 – 9:45 (L19) Clinical Phases
*T.B.A.
9:45 – 10:30 (L20) Benefit/risk assessment / Pharmacovigilance
Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada
10:30 – 11:00 Coffee Break11:00 – 11:45 (L21) Market access
*T.B.A.
11:45 – 12:30 (L22) “Beyond the pill”: Gene Editing and Ethical Concerns
Pierre Cordelier, INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France
12:30 – 14:00 Lunch
SESSION IX: PHARMACO ECONOMICS & INTELLECTUAL PROPERTY
Chairperson: Jordi Quintana
14:00 – 15:00 (L23) Pharmaco-economics
*T.B.A.
15:00 – 16:00 (L24) Intellectual Property
*T.B.A.
16:00 – 16:30 Coffee Break
16:30 – 18:00 Visit Laboratories at University of Sao Paulo Campus
THURSDAY, March 22nd – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION X: START-UP CREATION, INVESTMENT & BUSINESS DEVELOPMENT
Chairperson: Jordi Quintana & Claudio Costa-Neto
09:00 – 09:45 (L25) Public-Private Partnership for Drug Discovery and Development
Jordi Quintana, Barcelona Scientific and Technological Park, Barcelona, Spain; and Steven Xanthoudakis, Merck Frosst Centre for Therapeutic Research in Montreal, Canada.
09:45 – 10:30 (L26) Start-up Creation
Mark Kester, University of Virginia, USA
10:30 – 11:00 Coffee Break
11:00 – 12:00 (L27) Illustrative cases presented by an entrepreneur (III): Venture Capital Investment in Brazil
Invited Speaker: Fernando Reinach, former Professor at USP and founder of Fundo Pitanga (Venture Capital Fund)
12:30 – 14:00 Lunch
SESSION XI: CASE STUDY IN INTELLECTUAL PROPERTY
Chairperson: Jordi Quintana, Rémy Poupot, Pierre Cordelier
14:00 – 15:30 Case presentation and outline of challenges
14:30 – 16:00 Group session (students work in small teams)
16:00 – 16:30 Coffee Break
16:30 – 18:00 Each team reports / General discussion
FRIDAY, March 23rd – 2018
Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).
SESSION XII: CAREERS & PERSPECTIVES IN LIFE SCIENCES
09:00 – 10:30 (L28) Careers in Life Sciences (Panel)
The Organizing Committee & Invited Speakers.
10:30 – 11:00 Coffee Break
11:00 – 12:00 (L29) Broadening the horizons: Systems Biology as an approach to identify problems and possible solutions
Helder Nakaya, Faculty of Pharmaceutical Sciences, USP, São Paulo.
12:00 – 14:00 Lunch
SESSION XIII: CLOSING SESSION
Chair: The Organizing Committee
14:00 – 15:00 (KNL3) – Keynote Closing Lecture 3. Illustrative cases presented by an entrepreneur (IV): Foundation and development of Recepta Biopharma
Invited Speaker: Fernando Perez, former Professor at USP and founder of Recepta Biopharma.
15:00 – 16:00 (KNL4) – Keynote Closing Lecture 4.
Michel Bouvier, Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Canada.
16:00 – 16:15 SSM10 Evaluation / Final Discussion
16:15 – 16:30 SSM10 closing remarks and pre-launching of SSM11 in Montreal, Canada.
16:30 – 17:00 Farewell Coffee Break